Adaptive Biotechnologies Corp. (ADPT)
26.64
-1.53
(-5.43%)
USD |
NASDAQ |
Oct 30, 16:00
26.60
-0.04
(-0.15%)
After-Hours: 20:00
Adaptive Biotechnologies Cash and Short Term Investments (Annual) : 226.98M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 226.98M |
| December 31, 2024 | 222.29M |
| December 31, 2023 | 346.40M |
| December 31, 2022 | 498.20M |
| December 31, 2021 | 353.06M |
| Date | Value |
|---|---|
| December 31, 2020 | 688.27M |
| December 31, 2019 | 576.87M |
| December 31, 2018 | 165.02M |
| December 31, 2017 | 192.15M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Champions Oncology, Inc. | 4.872M |
| Medpace Holdings, Inc. | 497.05M |
| Avantor, Inc. | 365.40M |
| Personalis, Inc. | 239.95M |
| 10X Genomics, Inc. | 523.41M |